Marking a milestone in China’s drug regulatory landscape, the 2026 Revisions of China’s Drug Administration Law introduce data exclusivity and market exclusivity into the regulatory framework, establishing a multi‑dimensional…
Marking a milestone in China’s drug regulatory landscape, the 2026 Revisions of China’s Drug Administration Law introduce data exclusivity…